Company Compass Biotechnologies, Inc. Other OTC

US20452Q1031

Managers

Members of the board

Share class

Company contact information

Sector

Sector Alternative Medicine

Inactive Instrument

Bangi Inc. is focused on the acquisition, ownership and management of properties leased to experienced, state-licensed operators for regulated use of Cannabis facilities. The Company intends to acquire properties through sale-leaseback transactions and third-party purchases.

Managers	Title	Age	Since
Nicole Birch CEO	Chief Executive Officer	-	20-04-17
Mathew Knowles SAM	Sales & Marketing	-	19-07-21

Members of the board	Title	Age	Since
Nicole Birch CEO	Chief Executive Officer	-	20-04-17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	5,561,487,035	5,505,872,165 ( 99.00 %)	0	99.00 %

BANGI, Inc.

41000 Woodward Avenue Suite 350 East

48304, Bloomfield Hills

+833-251-7679

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B

Alternative Medicine